Kidney Diseases: Challenges and Opportunities of the Third Millenium

Since medical school Dr Bellasi has developed a strong interest in mineral metabolism abnormalities and their impact on the cardiovascular system in Chronic Kidney Disease (CKD) as well as normal kidney function individuals. After various internships at University Hospitals in Spain, Sweden, and Italy, he graduated from the Medical School of the University of Milan, Italy, in October 2002. He finalized his post-graduate training in Nephrology and graduated from the University of Milan in November 2007. He attended a cardio-nephrology research fellowship at Tulane University in New Orleans (LA), U.S.A and at Emory University in Atlanta (GA), U.S.A.. Furthermore, Dr Bellasi successfully completed a master in Epidemiology and Statistics at the University of Milan in 2009 and a postgraduate doctorate in Physiopathology, Pharmacology and Therapy of Metabolic Diseases at the University of Milan

From 2009 to 2011, Dr Bellasi served as Nephrology consultant at Azienda Universitaria-Ospedaliera Sant’Orsola-Malpighi in Bologna, Italy. From April 2011 to June 2018 served as Nephrology consultant at Ospedale Sant’Anna, ASST-Lariana di Como, Italy. From July 1st 2018 he serves at the Research, Innovation and Brand Reputation and from November 1st 2018 he is the medical director of the Clinical Trial Center (CTC) at Ospedale di Bergamo, ASST Papa Giovanni XXIII, Bergamo, Italy.

He is a coauthor of more than 150 publications (H-index 30, i10-index 68, citation 4072, source: Google Scholar, September 24th, 2019 – ORCID 0000-0001-7830-1645) mainly focused on screening, imaging, prevention and treatment of vascular calcification and mineral metabolism abnormalities. Dr Bellasi is coauthor of more than 60 abstracts presented in numerous national and international meetings. His research has been published in journals as Kidney International, Nephrology Dialysis and Transplantation, clinical Journal of the American Society of Nephrology, Hypertension, American Journal of Cardiology, American Journal of Kidney Disease, Current Opinion in Nephrology and Hypertension and Current Opinion in Cardiology. Dr Bellasi has given more than 250 invited seminars/keynote presentations to a variety of Academic institutes and high-profile international conferences.

From 2012 to 2015 he was one of the member of the Steering Committee of the Cardionephrology Working Group of the Italian Society of Nephrology and from 2013 to 2016 he served as a board member of the Steering Committee of the Italian Society of Nephrology. Between 2014 and 2018, he served as one of the Board Member of the Steering Research Committee of the Italian Society of Nephrology and since 2017 he is a board memeber of the Ethic Committee of ATS Insubria. In 2018, he co-founded the Italian Association of Cardio-Nefrology.

Dr. Bellasi is also currently a reviewer for numerous journals and he has a served in the editorial board of numerous Journal in the field of Cardio-Nephrology. In 2014, he was appointed Editor in Chief of Nefrocom.com.Between 2014 and 2018 he served as Editor in Chief of Nephrology@PointOfCare. Since 2017, he acts as Co Editor in Chief  of the Journal of Nephrology, and since 2018 as theme editor for CKD-MBD for Nephrology. In 2019 he was apointed associate editor of Atherosclerosis. Finally, he is an editorial board member of  Springer Nature Comprehensive Medicine and Giornale Italiano di Nefrologia. In June 2018, he was appointed guest editor of the special issue entitled “Clinical Symptoms, Diagnostics and Treatments of Chronic Kidney Diseases (CKD)” for the Journal of Clinical Medicine“